Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China.
Wu X, Wu G, Ma P, Wang R, Li L, Chen Y, Xu J, Li Y, Li Q, Yang Y, Wang L, Xin X, Qiao Y, Fu G, Huang X, Su B, Zhang T, Wang H, Zou H.
Wu X, et al. Among authors: wang h.
Nat Commun. 2023 Sep 2;14(1):5334. doi: 10.1038/s41467-023-41051-w.
Nat Commun. 2023.
PMID: 37660054
Free PMC article.
Here we report a retrospective study comparing all-cause mortality among PLHIV in China who were on different initial ART regimens (nevirapine, efavirenz, dolutegravir, lopinavir, and others [including darunavir, raltegravie, elvitegravir and rilpivirine]) between 2017 and …
Here we report a retrospective study comparing all-cause mortality among PLHIV in China who were on different initial ART regimens (n …